SAZ.DE - STADA Arzneimittel Aktiengesellschaft

XETRA - XETRA Delayed Price. Currency in EUR
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,139,220
Cost of Revenue1,105,313
Gross Profit1,033,907
Operating Expenses
Research Development-
Selling General and Administrative-
Non Recurring-
Total Operating Expenses1,881,416
Operating Income or Loss257,804
Income from Continuing Operations
Total Other Income/Expenses Net-
Earnings Before Interest and Taxes257,804
Interest Expense-51,831
Income Before Tax-
Income Tax Expense31,938
Minority Interest-
Net Income From Continuing Ops-
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect Of Accounting Changes-
Other Items-
Net Income
Net Income85,904
Preferred Stock And Other Adjustments-
Net Income Applicable To Common Shares-